Hong Kong
-
Artificial Intelligence, BioPharma
Sanofi Inks Another AI Alliance, This Time Partnering With Insilico Medicine
Sanofi will use Insilico Medicine’s tech to advance drug development candidates for up to six new targets. Disease indications were not disclosed, but the pharmaceutical giant said the new agreement will boost its drug discovery research in China.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
Chinese researcher defends gene-edited ‘CRISPR babies’ amid global outcry
Researchers in the field of gene editing have largely denounced the experiment by Jiankui He and a team of scientists, including after he defended his work at a conference Wednesday.
-
BSX pays out to OrbusNeich to settle stent lawsuit woes
Boston Scientific (BSX) has agreed to make an undisclosed, one-time payment to OrbusNeich to settle […]